Predicting cancer drivers: are we there yet?

10.1186/gm388

Saved in:
Bibliographic Details
Main Authors: Krishnan, V.G, Ng, P.C
Other Authors: MEDICINE
Format: Note
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/181841
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-181841
record_format dspace
spelling sg-nus-scholar.10635-1818412024-11-11T04:03:04Z Predicting cancer drivers: are we there yet? Krishnan, V.G Ng, P.C MEDICINE B Raf kinase cetuximab panitumumab protein p53 cancer cell cancer research cancer therapy cell cycle colorectal cancer cost driver mutation drug sensitivity gene function gene mutation gene product gene sequence genetic correlation genetic variability germ line human loss of function mutation melanoma metastasis missense mutation neoplasm note nucleic acid base substitution oncogene K ras passenger mutation point mutation prediction priority journal protein function scientist single nucleotide polymorphism somatic mutation treatment outcome tumor growth 10.1186/gm388 Genome Medicine 4 11 88 2020-10-28T07:28:27Z 2020-10-28T07:28:27Z 2012 Note Krishnan, V.G, Ng, P.C (2012). Predicting cancer drivers: are we there yet?. Genome Medicine 4 (11) : 88. ScholarBank@NUS Repository. https://doi.org/10.1186/gm388 1756994X https://scholarbank.nus.edu.sg/handle/10635/181841 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic B Raf kinase
cetuximab
panitumumab
protein p53
cancer cell
cancer research
cancer therapy
cell cycle
colorectal cancer
cost
driver mutation
drug sensitivity
gene function
gene mutation
gene product
gene sequence
genetic correlation
genetic variability
germ line
human
loss of function mutation
melanoma
metastasis
missense mutation
neoplasm
note
nucleic acid base substitution
oncogene K ras
passenger mutation
point mutation
prediction
priority journal
protein function
scientist
single nucleotide polymorphism
somatic mutation
treatment outcome
tumor growth
spellingShingle B Raf kinase
cetuximab
panitumumab
protein p53
cancer cell
cancer research
cancer therapy
cell cycle
colorectal cancer
cost
driver mutation
drug sensitivity
gene function
gene mutation
gene product
gene sequence
genetic correlation
genetic variability
germ line
human
loss of function mutation
melanoma
metastasis
missense mutation
neoplasm
note
nucleic acid base substitution
oncogene K ras
passenger mutation
point mutation
prediction
priority journal
protein function
scientist
single nucleotide polymorphism
somatic mutation
treatment outcome
tumor growth
Krishnan, V.G
Ng, P.C
Predicting cancer drivers: are we there yet?
description 10.1186/gm388
author2 MEDICINE
author_facet MEDICINE
Krishnan, V.G
Ng, P.C
format Note
author Krishnan, V.G
Ng, P.C
author_sort Krishnan, V.G
title Predicting cancer drivers: are we there yet?
title_short Predicting cancer drivers: are we there yet?
title_full Predicting cancer drivers: are we there yet?
title_fullStr Predicting cancer drivers: are we there yet?
title_full_unstemmed Predicting cancer drivers: are we there yet?
title_sort predicting cancer drivers: are we there yet?
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/181841
_version_ 1821197906338643968